{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:20:52Z","timestamp":1772166052387,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T00:00:00Z","timestamp":1724457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T00:00:00Z","timestamp":1724457600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","award":["233555"],"award-info":[{"award-number":["233555"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","award":["233555"],"award-info":[{"award-number":["233555"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"DOI":"10.1186\/s12913-024-11442-w","type":"journal-article","created":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T06:10:13Z","timestamp":1724479813000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Economic implications of step-down outpatient management for fever and neutropenia episodes in pediatric cancer patients: a cost minimization analysis"],"prefix":"10.1186","volume":"24","author":[{"given":"Martha J.","family":"Avil\u00e9s-Robles","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfonso","family":"Reyes-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,24]]},"reference":[{"issue":"9","key":"11442_CR1","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1200\/JCO.22.02224","volume":"41","author":"T Lehrnbecher","year":"2023","unstructured":"Lehrnbecher T, Robinson PD, Ammann RA, Fisher B, Patel P, Phillips R, et al. Guideline for the management of Fever and Neutropenia in Pediatric patients with Cancer and hematopoietic cell transplantation recipients: 2023 update. J Clin Oncol. 2023;41(9):1774\u201385.","journal-title":"J Clin Oncol"},{"issue":"6","key":"11442_CR2","doi-asserted-by":"publisher","first-page":"857","DOI":"10.4067\/s0716-10182021000600857","volume":"38","author":"ME Santolaya","year":"2021","unstructured":"Santolaya ME, Contardo V, Torres JP, L\u00f3pez-Medina E, Rosanova MT, \u00c1lvarez AM, et al. Manejo De Los episodios de neutropenia febril en ni\u00f1os con c\u00e1ncer. Consenso De La Sociedad Latinoamericana De Infectolog\u00eda Pedi\u00e1trica 2021 [Management of episodes of febrile neutropenia in children with cancer. Consensus of the Latin American Society of Pediatric Infectious Diseases 2021]. Rev Chil Infectol. 2021;38(6):857\u2013909.","journal-title":"Rev Chil Infectol"},{"issue":"3","key":"11442_CR3","first-page":"CD009031","volume":"3","author":"R Rivas-Ruiz","year":"2019","unstructured":"Rivas-Ruiz R, Villasis-Keever M, Miranda-Novales G, Castel\u00e1n-Mart\u00ednez OD, Rivas-Contreras S. Outpatient treatment for people with cancer who develop a low-risk febrile neutropaenic event. Cochrane Database Syst Rev. 2019;3(3):CD009031.","journal-title":"Cochrane Database Syst Rev"},{"issue":"23","key":"11442_CR4","doi-asserted-by":"publisher","first-page":"100394","DOI":"10.1016\/j.eclinm.2020.100394","volume":"15","author":"GM Haeusler","year":"2020","unstructured":"Haeusler GM, Phillips R, Slavin MA, Babl FE, De Abreu Lourenco R, Mechinaud F, et al. Australian PICNICC study group and the PREDICT network. Re-evaluating and recalibrating predictors of bacterial infection in children with cancer and febrile neutropenia. EclinicalMedicine. 2020;15(23):100394.","journal-title":"EclinicalMedicine"},{"issue":"11","key":"11442_CR5","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1093\/jpids\/piac080","volume":"11","author":"M Avil\u00e9s-Robles","year":"2022","unstructured":"Avil\u00e9s-Robles M, Schnur JJ, Dorantes-Acosta E, M\u00e1rquez-Gonz\u00e1lez H, Ocampo-Ram\u00edrez LA, Chawla NV. Predictors of septic shock or bacteremia in children experiencing febrile Neutropenia Post-chemotherapy. J Pediatr Infect Dis Soc. 2022;11(11):498\u2013503.","journal-title":"J Pediatr Infect Dis Soc"},{"issue":"18","key":"11442_CR6","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1200\/JCO.2016.71.7017","volume":"35","author":"T Lehrnbecher","year":"2017","unstructured":"Lehrnbecher T, Robinson P, Fisher B, Alexander S, Ammann RA, Beauchemin M, et al. Guideline for the management of Fever and Neutropenia in Children with Cancer and hematopoietic stem-cell transplantation recipients: 2017 update. J Clin Oncol. 2017;35(18):2082\u201394.","journal-title":"J Clin Oncol"},{"issue":"3","key":"11442_CR7","first-page":"CD009031","volume":"3","author":"R Rivas-Ruiz","year":"2019","unstructured":"Rivas-Ruiz R, Villasis\u2010Keever M, Miranda\u2010Novales G, Castel\u00e1n\u2010Mart\u00ednez OD, Rivas\u2010Contreras S. Outpatient treatment for people with cancer who develop a low\u2010risk febrile neutropaenic event. Cochrane Database Syst Rev. 2019;3(3):CD009031.","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"11442_CR8","doi-asserted-by":"publisher","first-page":"e552","DOI":"10.1200\/JOP.2016.019588","volume":"13","author":"E Tai","year":"2017","unstructured":"Tai E, Guy GP, Dunbar A, Richardson LC. Cost of Cancer-related Neutropenia or Fever hospitalizations, United States, 2012. J Oncol Pract. 2017;13(6):e552\u201361.","journal-title":"J Oncol Pract"},{"issue":"3","key":"11442_CR9","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1002\/cncr.24773","volume":"116","author":"N Lathia","year":"2010","unstructured":"Lathia N, Mittmann N, DeAngelis C, Knowles S, Cheung M, Piliotis E, et al. Evaluation of direct medical costs of hospitalization for febrile neutropenia. Cancer. 2010;116(3):742\u20138.","journal-title":"Cancer"},{"issue":"6","key":"11442_CR10","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1007\/s00520-002-0429-1","volume":"11","author":"VC Costa","year":"2003","unstructured":"Costa VC, Ferraz MB, Petrilli AS, Pereira CA, Rogerio JW. Resource utilization and cost of episodes of febrile neutropenia in children with acute leukemias and lymphomas. Support Care Cancer. 2003;11(6):356\u201361.","journal-title":"Support Care Cancer"},{"key":"11442_CR11","doi-asserted-by":"crossref","unstructured":"Raisch DW, Holdsworth MT, Winter SS, Hutter JJ, Graham ML. Economic comparison of home-care-based versus hospital-based treatment of chemotherapy-induced febrile neutropenia in children. Value Health. 2003 Mar-Apr;6(2):158\u201366.","DOI":"10.1046\/j.1524-4733.2003.00219.x"},{"issue":"18","key":"11442_CR12","doi-asserted-by":"publisher","first-page":"3784","DOI":"10.1200\/JCO.2004.01.078","volume":"22","author":"ME Santolaya","year":"2004","unstructured":"Santolaya ME, Alvarez AM, Avil\u00e9s CL, Becker A, Cofr\u00e9 J, Cumsille MA, et al. Early hospital discharge followed by outpatient management versus continued hospitalization of children with cancer, fever, and neutropenia at low risk for invasive bacterial infection. J Clin Oncol. 2004;22(18):3784\u20139.","journal-title":"J Clin Oncol"},{"issue":"4","key":"11442_CR13","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1200\/JCO.2007.13.8222","volume":"26","author":"LS Elting","year":"2008","unstructured":"Elting LS, Lu C, Escalante CP, Giordano SH, Trent JC, Cooksley C, et al. Outcomes and cost of outpatient or inpatient management of 712 patients with febrile neutropenia. J Clin Oncol. 2008;26(4):606\u201311.","journal-title":"J Clin Oncol"},{"issue":"1","key":"11442_CR14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.5581\/1516-8484.20130002","volume":"35","author":"M Bellesso","year":"2013","unstructured":"Bellesso M. Febrile neutropenia studies in Brazil - treatment and cost management based on analyses of cases. Rev Bras Hematol Hemoter. 2013;35(1):3\u20134.","journal-title":"Rev Bras Hematol Hemoter"},{"issue":"30","key":"11442_CR15","doi-asserted-by":"publisher","first-page":"3984","DOI":"10.1200\/JCO.2011.35.1247","volume":"29","author":"AM Hendricks","year":"2011","unstructured":"Hendricks AM, Loggers ET, Talcott JA. Costs of home versus inpatient treatment for fever and neutropenia: analysis of a multicenter randomized trial. J Clin Oncol. 2011;29(30):3984\u20139.","journal-title":"J Clin Oncol"},{"issue":"6","key":"11442_CR16","doi-asserted-by":"publisher","first-page":"397","DOI":"10.2165\/00019053-200321060-00004","volume":"21","author":"F de Lalla","year":"2003","unstructured":"de Lalla F. Outpatient therapy for febrile neutropenia: clinical and economic implications. PharmacoEconomics. 2003;21(6):397\u2013413.","journal-title":"PharmacoEconomics"},{"issue":"6","key":"11442_CR17","doi-asserted-by":"publisher","first-page":"e28251","DOI":"10.1002\/pbc.28251","volume":"67","author":"MJ Avil\u00e9s-Robles","year":"2020","unstructured":"Avil\u00e9s-Robles MJ, Reyes-L\u00f3pez A, Otero-Mendoza FJ, Valencia-Garin AU, Pe\u00f1aloza-Gonz\u00e1lez JG, Rosales-Uribe RE, et al. Safety and efficacy of step-down to oral outpatient treatment versus inpatient antimicrobial treatment in pediatric cancer patients with febrile neutropenia: a noninferiority multicenter randomized clinical trial. Pediatr Blood Cancer. 2020;67(6):e28251.","journal-title":"Pediatr Blood Cancer"},{"key":"11442_CR18","volume-title":"Economic evaluation in clinical trials","author":"HA Glick","year":"2015","unstructured":"Glick HA, Doshi JA, Sonnad SS, Polsky D. Economic evaluation in clinical trials. 2nd ed. UK: Oxford University Press; 2015.","edition":"2"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-024-11442-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-024-11442-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-024-11442-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T06:15:35Z","timestamp":1724480135000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-024-11442-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,24]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["11442"],"URL":"https:\/\/doi.org\/10.1186\/s12913-024-11442-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2957478\/v1","asserted-by":"object"}]},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,24]]},"assertion":[{"value":"19 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research received ethical approval from the ethics committee of Hospital Infantil de M\u00e9xico Federico G\u00f3mez (HIM-2014-026). We declare that all methods were performed in accordance with relevant guidelines and regulations. Informed consent was obtained in writing from all subjects participating in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"981"}}